These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25656489)

  • 1. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Jan; 102():425-35. PubMed ID: 25459942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Electrophoresis; 2015 Feb; 36(4):577-87. PubMed ID: 25393935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Mol Biosyst; 2015 Sep; 11(9):2429-40. PubMed ID: 26131452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP/PS1 mouse model using integrated metabolomic approaches.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochimie; 2015 Mar; 110():119-128. PubMed ID: 25597416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences of peripheral plasma and liver metabolic profiling in APP/PS1 transgenic AD mice.
    Wu J; Fu B; Lei H; Tang H; Wang Y
    Neuroscience; 2016 Sep; 332():160-9. PubMed ID: 27393253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a
    Zhou Q; Zheng H; Chen J; Li C; Du Y; Xia H; Gao H
    Metab Brain Dis; 2018 Oct; 33(5):1661-1668. PubMed ID: 29946959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry.
    González-Domínguez R; Castilla-Quintero R; García-Barrera T; Gómez-Ariza JL
    Anal Biochem; 2014 Nov; 465():20-7. PubMed ID: 25064643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease.
    Fabelo N; Martín V; Marín R; Santpere G; Aso E; Ferrer I; Díaz M
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):868-81. PubMed ID: 22975585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.
    Durani LW; Hamezah HS; Ibrahim NF; Yanagisawa D; Nasaruddin ML; Mori M; Azizan KA; Damanhuri HA; Makpol S; Wan Ngah WZ; Tooyama I
    J Alzheimers Dis; 2018; 64(1):249-267. PubMed ID: 29889072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
    Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
    Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
    J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.